In a previous interview, Lee hinted that a period of market volatility is expected, as 2024 heads for a soft landing.

The FDA has approved a new preventive treatment for people with certain types of hemophilia that can reduce bleeding episodes, sometimes down to just a few per year.

In the latest market close, Pfizer (PFE) reached $29.08, with a -0.27% movement compared to the previous day. The stock's performance was behind the S&P 500's daily gain of 0.77%. Meanwhile, the Dow ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.03% of ...

In a press release, Town Manager Scott Crabtree and Director of Public Health John Fralick reported the town is hosting a COVID-19 and flu vaccine clinic on Oct 23. The clinic will go from 11:30 a.m.

Treatment with the vaccine did not improve progression-free survival in patients with HPV16-positive cervical and anogenital tumors.

A Pfizer Covid booster vaccination gave a fit 54-year-old chronic pain, NHS doctors found. Larry Lowe, from Omagh in Northern ...

Since the S&P 500's closing low two years ago, 73 stocks in the S&P 500 have rallied at least 100% while just 71 are down.

An investigational oral fatty acid synthase (FASN) inhibitor was associated with significant improvements in metabolic ...

A fever and a nasty cough can be symptoms of a range of respiratory illnesses. An antigen test that narrows down the culprits ...

We recently compiled a list of the David Einhorn’s Stock Portfolio: Top 10 Stocks to Buy. In this article, we are going to ...

The approval of Hympavzi Friday was a dose of good news for Pfizer, which is dealing with research setbacks and a challenge ...